The wack job that keeps putting the 400k on the ask must be
The wack job that keeps putting the 400k on the ask must be one of those lonely kind of people that have to act strangely to get attention. More shares than brain cells. Sad.
And their's somebody saying" look at me Mom, I got it to close under .03 today, aren't I special?" ( Probably the same fruit cake).
I will be adding this week to my stash. Those shares are locked up hard.
The key to the vault is a PPS of several dollars to start.
Name change to Conglomerate.
What part of "CONGLOMERATE" don't these special people get?
I know what I have thankfully.
Rainbows coming.
6
Univec Conglomerate Inc (UNVC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...
Continue Reading
America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...
Continue Reading
Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...
Continue Reading
In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...
Continue Reading
AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...
Continue Reading
Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...
Continue Reading
Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...
Continue Reading
Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...
Continue Reading
Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...
Continue Reading
Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...
Continue Reading
Top 5 Most Recently Viewed Articles
Bellring Brands Achieves Record Stock High in Financial Milestone Bellring Brands LLC (BRBR) has made headlines recently as its stock reached an impressive milestone, hitting an all-time high of $62.76. This remarkable increase signals a surge in investor confidence, demonstrated by the stock's substantial 1-year change of 46.23%. The performance of Bellring Brands has...
Continue Reading
Dr. Shelley Doumani-Semino Earns Pinnacle Lifetime Membership Renowned for her significant contributions to the field of addiction psychiatry, Dr. Shelley Doumani-Semino, MD, LFAPA, has been honored with the designation of Pinnacle Lifetime Member, as highlighted in The Inner Circle. This recognition celebrates her extensive work in addiction psychiatry and psychiatric...
Continue Reading
Conference Call Announcement for Financial Results Arcus Biosciences (NYSE: RCUS), a forward-thinking clinical-stage biopharmaceutical company, has announced plans for a significant conference call. The focus will be on discussing its financial results for the third quarter, as well as updates on its product pipeline, which is crucial for its commitment to provide...
Continue Reading
CareDx Gains Confidence as Investigations Conclude Recently, CareDx, Inc. (NASDAQ: CDNA) celebrated a significant victory as BTIG reaffirmed its Buy rating, coupled with an ambitious $40 price target for the company's stocks. This optimistic outlook emerged right after the Department of Justice (DOJ) completed its investigation, finding no evidence of misconduct and...
Continue Reading
Indaptus Therapeutics CEO to Speak at 2024 Maxim Healthcare Summit Indaptus Therapeutics, Inc. is set to make waves at the upcoming 2024 Maxim Healthcare Virtual Summit. The company's Chief Executive Officer, Jeffrey A. Meckler, will host a fireside chat during the event, which promises to be filled with insightful discussions about the company’s innovative approaches...
Continue Reading